Using Prothrombin Complex Concentrate for Severe Bleeding
Author Information
Author(s): Bruce David, Nokes Tim JC
Primary Institution: Derriford Hospital
Hypothesis
Can prothrombin complex concentrate (PCC) effectively treat severe bleeding in various clinical settings?
Conclusion
PCC is valuable in reversing anticoagulant effects and controlling bleeding in surgical patients.
Supporting Evidence
- Partial or complete haemostasis was achieved in 14 out of 18 cases (77.8%).
- 12 out of 24 patients (50%) died during the study, with two-thirds of deaths unrelated to bleeding.
- Considerable reduction in administration of other blood products was seen after PCC administration.
Takeaway
Doctors used a special medicine called PCC to help patients who were bleeding a lot, and it worked well for many of them.
Methodology
Retrospective analysis of 30 patients who received PCC, assessing outcomes and blood product use.
Potential Biases
Potential bias due to retrospective design and lack of control group.
Limitations
The study was retrospective, and outcomes cannot be solely attributed to PCC due to other treatments given.
Participant Demographics
Mean age of participants was 68.5 years, with a range from 41 to 82 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website